Author

H. E. Peck

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Assay:CRISPR screen· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Assay:multiome· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

D. Vanover· 2 shared P. J. Santangelo· 2 shared A. H. Zamat· 1 shared A. M. Harris· 1 shared A. Sivakumar· 1 shared C. A. Thiveaud· 1 shared C. Zurla· 1 shared E. L. Blanchard· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

D. Vanover

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioengineeringbioRxivPreprintDec 11, 2021

Sensitizing solid tumors to CAR-mediated cytotoxicity using synthetic antigens

L. Gamboa, A. H. Zamat, D. Vanover…·G. A. Kwong

This study develops synthetic antigens to enhance CAR T cell efficacy against solid tumors by reducing off-target effects and improving tumor targeting.

DOI 10.1101/2021.12.11.472238

mouseexperimental assay

𝕏 PostBluesky

BioengineeringbioRxivPreprintApr 24, 2020

Treating Influenza and SARS-CoV-2 via mRNA-encoded Cas13a

E. L. Blanchard, D. Vanover, S. S. Bawage…·P. J. Santangelo

This study uses mRNA-encoded Cas13a to target and reduce influenza and SARS-CoV-2 RNA in vitro and in a mouse model, showing potential for therapeutic applications.

DOI 10.1101/2020.04.24.060418

mouseCRISPR screen

𝕏 PostBluesky